Xtandi ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

xtandi

astellas pharma europe b.v. - enzalutamide - prostata neoplasmer - endokrin terapi - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

Empressin 20 IE/ ml নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

empressin 20 ie/ ml

orpha-devel handels und vertriebs gmbh - argipressinmonoacetat - konsentrat til infusjonsvæske, oppløsning - 20 ie/ ml